Adam Hill
Clinician, Mechanical Engineer and Chief Executive Officer at Oncimmune.
Dr. Adam M Hill MB PhD is a dual-qualified Clinician and Mechanical Engineer with a career built at the interface of industry, academia and health systems. Over the last 2 decades he has trained in surgery in the British Army; founded a successful applied research centre at Imperial College London; provided growth strategy and investment advice to global life science companies on behalf of the British Government; led the global medical function of a multinational, publicly-listed health IT company; and pivoted a Formula One team into a developer of health technology. Currently, Adam is a Visiting Professor in Global Health Innovation at Imperial College London, sits on the Value Creation Committee of Imperial College Health Partners and is Non Executive Director of Myrecovery.ai.
Visit website: https://oncimmune.com/board-of-directors/
See also: Oncimmune - Immunodiagnostic for detection and care of cancer.
Details last updated 08-Nov-2019
Adam Hill News
New blood test can detect lung cancer before symptoms show up
BBC - 10-Sep-2019
Detects 50% more early stage lung cancers and being expanded to detect other types
Read more...